Biocancell Therapeutics INC.
SEC CIK 1451980 · BICL.TA · last insider filing 2012-08-07
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hochberg Abraham | Director · Chief Scientist | filed 2009 - 2012 |
| Krupik Ruben | Director | filed 2011 - 2011 |
| Goldberg Ofer | Director | filed 2009 - 2011 |
| Nevo Doron | Director | filed 2009 - 2011 |
| Rappaport Hanoch | Director | filed 2009 - 2011 |
| Boim Aviv | Director | filed 2009 - 2010 |
| Yarkoni Orly | Director | filed 2010 - 2010 |
| Schlachet David | Director | filed 2010 - 2010 |
| Levitzki Alexander | Director | filed 2009 - 2009 |
| Barak Avi | Director · Chief Executive Officer | filed 2009 - 2009 |
| Ben Gur Jacob | Director | filed 2009 - 2009 |
| Epstein Nava | Director | filed 2009 - 2009 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Burgin Jonathan | Chief Financial Officer | filed 2011 - 2012 |
| Ben-Am Monique | VP Clinical Trials | filed 2011 - 2012 |
| Weinstein Ira | CFO and COO | filed 2009 - 2011 |
| Ohana Patricia | VP, Clinical Development | filed 2009 - 2011 |
| Danon URI | Chief Executive Officer | filed 2009 - 2010 |
| Landsberg Moshe | Vice President of Technology | filed 2009 - 2009 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.